ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR 04388780190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2019-02-11 for ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR 04388780190 manufactured by Roche Diagnostics.

Event Text Entries

[135715531] This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[135715532] The customer complained of a possible biotin interference for 1 patient tested for elecsys tsh assay (tsh), elecsys ft4 ii (ft4 ii), elecsys t3 (t3) and elecsys anti-tshr immunoassay (anti-tshr) on a cobas 8000 e 602 module. This medwatch will cover anti-tshr. Refer to medwatch with patient identifier (b)(6) for information on the tsh results, medwatch with patient identifier (b)(6) for information on the ft4 ii results and medwatch with patient identifier (b)(6) for information on the t3 results. The patient has multiple sclerosis and has been taking higher doses of biotin (3 x 100 mg per day) for the past 6 months. The patient takes biotin each day at 8:00 a. M. , 3:00 p. M. And 11:00 p. M. The patient sample in question was drawn at 8:30 a. M. On (b)(6) 2018. The patient didn't remember if he had taken biotin at 8:00 a. M. Or not. The customer performed a procedure on the patient sample to remove the biotin from the sample and repeated the sample. Refer to attached data for the patient results. No erroneous results were reported outside of the laboratory. There was no allegation that an adverse event occurred. The e602 module serial number was (b)(4). The patient sample could not be provided for investigation. Product labeling states that the anti-tshr assay is unaffected by biotin levels up to 10 ng/ml samples should not be taken from patients receiving therapy with high biotin doses (i. E. > 5 mg/day) until at least 8 hours following the last biotin administration. Since the sample could not be provided, the biotin interference could not be investigated. From the data provided, a general reagent issue can be excluded. The investigation did not identify a product problem. The cause of the event could not be determined.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2019-00542
MDR Report Key8325420
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2019-02-11
Date of Report2019-02-11
Date of Event2018-10-17
Date Mfgr Received2019-01-25
Date Added to Maude2019-02-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameANTI-TSHR, ANTIBODIES TO TSH RECEPTOR
Generic NameANTI-TSHR IMMUNOASSAY
Product CodeJZO
Date Received2019-02-11
Model NumberNA
Catalog Number04388780190
Lot NumberASKU
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2019-02-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.